Bolt Biotherapeutics annual total assets
2020
2021
2022
2023
2024
2025
Bolt Biotherapeutics Total Assets Growth & History (BOLT)
Bolt Biotherapeutics's total assets was $56.7M for fiscal 2025.
View full Bolt Biotherapeutics company overviewBolt Biotherapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $56.7M | −$42.9M | −43.04% |
| 2024 | 2024-12-31 | $99.6M | −$60.2M | −37.65% |
| 2023 | 2023-12-31 | $159.8M | −$68.0M | −29.86% |
| 2022 | 2022-12-31 | $227.8M | −$79.9M | −25.97% |
| 2021 | 2021-12-31 | $307.7M | $261.2M | +561.16% |
| 2020 | 2020-12-31 | $46.5M | — | — |
Bolt Biotherapeutics quarterly total assets
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $40.3M | −$35.2M | −46.56% |
| Q1 2026 | 2026-03-31 | $48.0M | −$37.8M | −44.06% |
| Q4 2025 | 2025-12-31 | $56.7M | −$42.9M | −43.04% |
| Q3 2025 | 2025-09-30 | $65.1M | −$44.3M | −40.50% |
| Q2 2025 | 2025-06-30 | $75.5M | −$48.7M | −39.20% |
| Q1 2025 | 2025-03-31 | $85.9M | −$57.0M | −39.91% |
| Q4 2024 | 2024-12-31 | $99.6M | −$60.2M | −37.65% |
| Q3 2024 | 2024-09-30 | $109.3M | −$66.0M | −37.65% |
| Q2 2024 | 2024-06-30 | $124.2M | −$66.5M | −34.88% |
| Q1 2024 | 2024-03-31 | $142.9M | −$63.3M | −30.70% |
| Q4 2023 | 2023-12-31 | $159.8M | −$68.0M | −29.86% |
| Q3 2023 | 2023-09-30 | $175.4M | −$70.2M | −28.57% |
| Q2 2023 | 2023-06-30 | $190.7M | −$69.5M | −26.72% |
| Q1 2023 | 2023-03-31 | $206.2M | −$76.6M | −27.09% |
| Q4 2022 | 2022-12-31 | $227.8M | −$79.9M | −25.97% |
| Q3 2022 | 2022-09-30 | $245.5M | −$88.0M | −26.40% |
| Q2 2022 | 2022-06-30 | $260.2M | −$86.8M | −25.02% |
| Q1 2022 | 2022-03-31 | $282.8M | −$41.8M | −12.89% |
| Q4 2021 | 2021-12-31 | $307.7M | $261.2M | +561.16% |
| Q3 2021 | 2021-09-30 | $333.6M | — | — |
| Q2 2021 | 2021-06-30 | $347.1M | — | — |
| Q1 2021 | 2021-03-31 | $324.6M | — | — |
| Q4 2020 | 2020-12-31 | $46.5M | — | — |
Bolt Biotherapeutics total assets trends
Over the last five fiscal years, Bolt Biotherapeutics's total assets increased from $46.5M to $56.7M, a change of $10.2M. The latest reported quarter, Q2 2026, shows $40.3M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bolt Biotherapeutics source filings ↗